Log in to search using one of your social media accounts:

 

EpiVax Launches Precision Cancer Immunotherapy Venture, EpiVax Oncology
PROVIDENCE, R.I., Sept. 25, 2017 -- (Healthcare Sales & Marketing Network) -- EpiVax, Inc., a leader in the fields of immunogenicity assessment, vaccine design, and immune-engineering today announced the launch of EpiVax Oncology Inc., a company focused o... Biopharmaceuticals, Personalized Medicine, Oncology EpiVax, EpiVax Oncology, epitopes, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 25, 2017 Category: Pharmaceuticals Source Type: news

IsoRay Announces "Long-term PSA Outcomes in a Single Institution, Prospective Randomized Cesium-131 / Iodine-125 Permanent Prostate Brachytherapy Trial" Poster Presentation at 2017 Annual American Society for Radiation Oncology (ASTRO) Conference
9-Year Study Demonstrates Durable Positive Outcomes and Statistically Identical Results of Cesium-131 RICHLAND, Wash., Sept. 25, 2017 -- (Healthcare Sales & Marketing Network) -- IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator ... Devices, Oncology IsoRay, brachytherapy, radiotherapy, cesium, iodine, prostate cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 25, 2017 Category: Pharmaceuticals Source Type: news

Cumberland Pharmaceuticals Launches Promotion of Totect(R) in The U.S. for Emergency Oncology Intervention
NASHVILLE, Tenn. and BURTON ON TRENT, England, Sept. 25, 2017 -- (Healthcare Sales & Marketing Network) -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX, 'Cumberland') and Clinigen Group plc (AIM:CLIN, 'Clinigen'), announced today the promotional launch o... Biopharmaceuticals, Oncology, Product Launch Cumberland Pharmaceuticals, Totect, dexrazoxane, anthracycline, extravasation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 25, 2017 Category: Pharmaceuticals Source Type: news

Bracco Diagnostics Inc. Receives U.S. FDA Approval for TAGITOL(TM) V (Barium Sulfate) Oral Suspension
First Imaging Agent Approved for use During Computed Tomographic (CT) Colonography (CTC) procedures MONROE TOWNSHIP, N.J., Sept. 25, 2017 -- (Healthcare Sales & Marketing Network) -- Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A.... Biopharmaceuticals, Radiology, FDA Bracco Diagnostics, TAGITOL V, barium sulfate, virtual colonoscopy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 25, 2017 Category: Pharmaceuticals Source Type: news

Allergan Announces Tessa Hilado, Executive Vice President and Chief Financial Officer, to Retire from Company
DUBLIN, Ireland, Sept. 25, 2017 --(Healthcare Sales & Marketing Network) --Allergan plc (NYSE: AGN) a leading global biopharmaceutical company, today announced that Tessa Hilado, Executive Vice President and Chief Financial Officer, has decided to retire f... Biopharmaceuticals, Personnel Allergan (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 25, 2017 Category: Pharmaceuticals Source Type: news

Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate(TM) Devices with the HeartLogic(TM) Heart Failure Diagnostic
MARLBOROUGH, Mass., Sept. 25, 2017 -- (Healthcare Sales & Marketing Network) -- Boston Scientific (NYSE: BSX) has launched the Resonate™ family of implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) sys... Devices, Cardiology, FDA Boston Scientific, Resonate, ICD , CRT-D, SmartCRT, HeartLogic (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 25, 2017 Category: Pharmaceuticals Source Type: news

Lannett's Board Of Directors Initiates CEO Search
CEO Arthur Bedrosian to Step Down Upon Naming of a Successor Company Submits 505(b)(2) New Drug Application for Its Proprietary Anesthetic Product, Cocaine Hydrochloride (HCl) Topical Solution PHILADELPHIA, Sept. 25, 2017 -- (Healthcare Sales & Marke... Biopharmaceuticals, Generics, Personnel, FDA Lannett Company, Cocaine HCl (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 25, 2017 Category: Pharmaceuticals Source Type: news

TapImmune Appoints Peter Hoang as President and Chief Executive Officer
JACKSONVILLE, Fla., Sept. 25, 2017 -- (Healthcare Sales & Marketing Network) -- TapImmune, Inc. (NASDAQ: TPIV), a clinical-stage immuno-oncology company specializing in the development of immunotherapies targeting women's cancers, today announced that the... Biopharmaceuticals, Oncology, Personnel TapImmune, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 25, 2017 Category: Pharmaceuticals Source Type: news

Elekta and Brainlab Collaborate to Streamline Treatment Workflows for Stereotactic Radiation Therapy
Integration of Versa HD linear accelerator and ExacTrac empowers clinicians to optimize radiation therapy inside and outside the brain SAN DIEGO, September 22, 2017 -- (Healthcare Sales & Marketing Network) -- Elekta (EKTA-B.ST) and Brainlab have recon... Devices, Oncology, Neurosurgery Elekta, Brainlab, Versa HD, ExacTrac, stereotactic, radiosurgery, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 22, 2017 Category: Pharmaceuticals Source Type: news

Abbott Secures FDA Approval for MRI-Compatibility for the Company's Ellipse(TM) ICD
FDA APPROVAL OF MR-CONDITIONAL LABELING FOR THE ELLIPSE™ ICD FAMILY ADDS ANOTHER PATIENT-CENTRIC BENEFIT TO A DEVICE DESIGNED TO OPTIMIZE THE TREATMENT OF ABNORMALLY FAST HEART RHYTHMS ABBOTT PARK, Ill., Sept. 22, 2017 -- (Healthcare Sales & Marketing N... Devices, Cardiology, FDA Abbott, Ellipse ICD, implantable cardioverter defibrillator (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 22, 2017 Category: Pharmaceuticals Source Type: news

Bayer Appoints Dr. Sharon James Head of Global Innovation and Development for Consumer Health
BASEL, Switzerland, Sept. 22, 2017 -- (Healthcare Sales & Marketing Network) -- Bayer today announced the appointment of Dr. Sharon James as Head of the Global Innovation & Development (I&D) organization of the Consumer Health Division, effective October ... Biopharmaceuticals, Personnel Bayer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 22, 2017 Category: Pharmaceuticals Source Type: news

ManaMed Inc. Introduces PlasmaFlow, The World's First FDA-Approved Digital and Tubeless Deep Vein Thrombosis Prevention Device
PlasmaFlow Is Deep Vein Thrombosis (DVT) Prevention Made Simple SANTA ANA, Calif., Sept. 21, 2017 -- (Healthcare Sales & Marketing Network) -- The company's historical first FDA-approved portable and tubeless DVT prevention device is now available to m... Devices, Product Launch ManaMed, PlasmaFlow, Deep Vein Thrombosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 21, 2017 Category: Pharmaceuticals Source Type: news

Paragon 28(R) launches 5th metatarsal fracture specific plating system, expanding the Baby Gorilla(TM) Mini Plating System offering
ENGLEWOOD, Colo., Sept. 21, 2017 -- (Healthcare Sales & Marketing Network) -- Since its inception, Paragon 28 has obsessed over every aspect of foot and ankle surgery. Committed to creating tailored solutions to improve surgical outcomes, Paragon 28 has l... Devices, Orthopaedic, Product Launch Paragon 28, Baby Gorilla, 5th Metatarsal, Plating System, foot and ankle surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 21, 2017 Category: Pharmaceuticals Source Type: news

FDA Releases Cefaly(R) for Acute Treatment of Migraine Attacks
NEW YORK, Sept. 21, 2017 -- (Healthcare Sales & Marketing Network) -- CEFALY Technology announces today that on Friday, September 15th, the U.S. Food and Drug Administration (FDA) released the use of a new Cefaly® medical device for the acute treatmen... Devices, Neurology, FDA CEFALY Technology, trigeminal nerve stimulation, e-TNS, migraine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 21, 2017 Category: Pharmaceuticals Source Type: news

Varian Announces Penn Medicine Treats World's First Patient on Halcyon System
PALO ALTO, Calif., Sept. 21, 2017 -- (Healthcare Sales & Marketing Network) -- Varian Medical Systems (NYSE: VAR) today announced a patient at Penn Medicine, with head & neck cancer, became the first person in the world to be treated on Varian's Halcyon™ ... Devices, Oncology Varian Medical Systems, Halcyon System, IMRT, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 21, 2017 Category: Pharmaceuticals Source Type: news

European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
First approved immunotherapy for rare and aggressive skin cancer in the European Union, with initial launches planned in Germany and the UK Builds on Bavencio's previous accelerated approvals in the US and recent approval in Switzerland Approval base... Biopharmaceuticals, Oncology, Regulatory Merck KGaA, Pfizer, BAVENCIO, avelumab, Merkel cell carcinoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 21, 2017 Category: Pharmaceuticals Source Type: news

DURECT Appoints Dr. Myriam Theeuwes as Senior Vice President, Clinical Development
CUPERTINO, Calif., Sept. 20, 2017 -- (Healthcare Sales & Marketing Network) -- DURECT Corporation (Nasdaq: DRRX) announced today that Dr. Myriam Theeuwes has joined DURECT as Senior Vice President, Clinical Development. Dr. Theeuwes joins DURECT from Joh... Biopharmaceuticals, Personnel DURECT, Epigenetic Regulator, nonalcoholic steatohepatitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 20, 2017 Category: Pharmaceuticals Source Type: news

Arvinas Appoints Dr. John Houston as President and Chief Executive Officer
NEW HAVEN, Conn., Sept. 20, 2017 -- (Healthcare Sales & Marketing Network) -- Arvinas LLC, a private biotechnology company creating a new class of drugs based on protein degradation, today announced the appointment of John Houston, Ph.D., as president and... Biopharmaceuticals, Personnel Arvinas, PROteolysis TArgeting Chimeras (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 20, 2017 Category: Pharmaceuticals Source Type: news

Trovagene Strengthens Board of Directors with Appointment of Oncology Development Veteran Dr. Athena Countouriotis
Dr. Athena Countouriotis joins Trovagene's Board of Directors, bringing significant experience in oncology clinical development and orphan indications SAN DIEGO, Sept. 20, 2017 -- (Healthcare Sales & Marketing Network) -- Trovagene, Inc. (NASDAQ: TROV... Biopharmaceuticals, Oncology, Personnel Trovagene, Precision Cancer Monitoring, circulating tumor DNA (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 20, 2017 Category: Pharmaceuticals Source Type: news

AIVITA Biomedical Announces New Discovery with Applications to Regenerative Medicine, Skin Aging and Hair Growth
Company discovers new methods of capturing and using short-range intercellular signals to stimulate a healthy cell environment IRVINE, Calif., Sept. 19, 2017 -- (Healthcare Sales & Marketing Network) -- AIVITA Biomedical today announced the discovery o... Biopharmaceuticals, Regenerative Medicine, Dermatology AIVITA Biomedical, intercellular signaling, stem cell niche, stem cell (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 19, 2017 Category: Pharmaceuticals Source Type: news

Organogenesis Names New Chief Commercial Officer and Chief Operating Officer
Senior Leadership Team Announced as Company Expands Commercial Operations, Product Portfolio CANTON, Mass., Sept. 19, 2017 -- (Healthcare Sales & Marketing Network) -- Organogenesis Inc., a commercial leader in the field of regenerative medicine with a... Devices, Regenerative Medicine, Wound Care, Personnel Organogenesis, acellular biomaterials (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 19, 2017 Category: Pharmaceuticals Source Type: news

Esteemed Researcher and Clinical Oncologist W. Michael Korn, M.D. Joins Caris Life Sciences as Chief Medical Officer
Executive Appointment Further Strengthens the Company's Position as a Precision Medicine Leader Translating Molecular Insights into Therapeutic Action IRVING, Texas, Sept. 19, 2017 -- (Healthcare Sales & Marketing Network) -- Caris Life Sciences®, ... Diagnostics, Personalized Medicine, Oncology, Personnel Caris Life Sciences, Caris Molecular Intelligence, ADAPT Biotargeting System (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 19, 2017 Category: Pharmaceuticals Source Type: news

Varian to Showcase Latest Technologies and Software for Advanced Cancer Care at ASTRO 2017
PALO ALTO, Calif., Sept. 19, 2017 -- (Healthcare Sales & Marketing Network) -- Varian Medical Systems (NYSE: VAR) today announced it will be demonstrating its new Halcyon™ platform for simplifying and enhancing virtually every aspect of image-guided volum... Devices, Oncology Varian Medical Systems, HyperArc, Halcyon, ProBeam, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 19, 2017 Category: Pharmaceuticals Source Type: news

ARKRAY launches ADAMS(TM) A1c HA-8180V System for hemoglobin A1c testing
EDINA, Minn., Sept. 18, 2017 -- (Healthcare Sales & Marketing Network) -- U.S. ARKRAY, Inc. (ARKRAY) announces the launch of the ADAMS™ A1c HA-8180V System for hemoglobin A1c testing. The system obtained FDA 510(k) clearance as an aid in the diagnosis and... Diagnostics, FDA, Product Launch ARKRAY, A1c HA-8180V System, hemoglobin A1c (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 18, 2017 Category: Pharmaceuticals Source Type: news

Recros Medica Appoints Thomas A. Albright as President and CEO
SAN DIEGO, Sept. 18, 2017 -- (Healthcare Sales & Marketing Network) -- Recros Medica, Inc., a development stage medical aesthetic device company focused on reducing skin laxity and focal contouring, announced today that Thomas A. Albright has been named P... Devices, Dermatology, Personnel Recros Medica, Rotational Fractional Resection (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 18, 2017 Category: Pharmaceuticals Source Type: news

Tetracore(R) Inc. Announces European Approval of the T-COR 8(TM) Portable Real-time PCR Thermocycler
The next generation molecular diagnostics platform introduces novel connectivity solution designed to bring testing closer to the patient ROCKVILLE, Md., Sept. 18, 2017 -- (Healthcare Sales & Marketing Network) -- Tetracore today announced that the T-CO... Diagnostics, Regulatory Tetracore, T-COR 8, real-time PCR (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 18, 2017 Category: Pharmaceuticals Source Type: news

Urovant Sciences Appoints Keith A. Katkin as Chief Executive Officer
Former CEO of Avanir Pharmaceuticals joins Roivant family of companies Plans to initiate confirmatory Phase 3 program of vibegron by early 2018 BASEL, Switzerland, Sept. 18, 2017 -- (Healthcare Sales & Marketing Network) -- Urovant Sciences, a globa... Biopharmaceuticals, Urology, Personnel Urovant Sciences, Vibegron (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 18, 2017 Category: Pharmaceuticals Source Type: news

Halyard Health Announces New Data Supporting COOLIEF* Cooled RF for the Treatment of Chronic Osteoarthritis Knee Pain
Study finds COOLIEF* Cooled RF provides significantly greater and longer-lasting pain relief, improved physical function and higher patient satisfaction than intra-articular steroid injections (1) ALPHARETTA, Ga., Sept. 18, 2017 -- (Healthcare Sales & M... Devices, Orthopaedic Halyard Health, COOLIEF, Cooled Radiofrequency, osteoarthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 18, 2017 Category: Pharmaceuticals Source Type: news

Kaleido Biosciences Announces Appointment of Mike Bonney as CEO and Completion of Additional Fundraising
Mike Bonney, former CEO of Cubist Pharmaceuticals, to lead Kaleido through its next phase of growth $65 million in funds raised since its founding in 2015 Funds to advance Kaleido's robust pipeline of novel microbiome therapies BEDFORD, Mass., Sep... Biopharmaceuticals, Personnel, Venture Capital Kaleido Biosciences, microbiome (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 18, 2017 Category: Pharmaceuticals Source Type: news

Abide Therapeutics Appoints Dr. Sapna Srivastava As Chief Financial and Strategy Officer
SAN DIEGO, Sept. 18, 2017 -- (Healthcare Sales & Marketing Network) -- Abide Therapeutics, a developer of innovative pharmaceuticals, announced today the appointment of Sapna Srivastava, Ph.D., to the position of Chief Financial and Strategy Officer. Dr. ... Biopharmaceuticals, Personnel Abide Therapeutics, serine hydrolase (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 18, 2017 Category: Pharmaceuticals Source Type: news

BioVentrix announces the 1st Revivent TC(TM) TransCatheter Ventricular Enhancement procedure for Ischemic Cardiomyopathy treatment at the University Heart Center Zurich in Switzerland
SAN RAMON, Calif., and ZURICH, Sept. 18, 2017 -- (Healthcare Sales & Marketing Network) -- BioVentrix, Inc. a pioneer of technologies and procedures for less invasive treatment of heart failure (HF), today announced the first clinical use of its closed-ch... Devices, Interventional, Cardiology BioVentrix, Revivent TC, TransCatheter, Ventricular Enhancement (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 18, 2017 Category: Pharmaceuticals Source Type: news

Myriad Genetics Announces Positive Data Supporting New riskScore(TM) Test at the 36th Annual Conference of the National Society of Genetic Counselors
Validation of Residual Risk Score to Predict Breast Cancer Risk in Women without Hereditary Cancer Mutations Is Highly Statistically Significant SALT LAKE CITY, Sept. 15, 2017 -- (Healthcare Sales & Marketing Network) -- Myriad Genetics, Inc. (NASDAQ:MY... Diagnostics, Personalized Medicine, Oncology Myriad Genetics, riskScore, breast cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 15, 2017 Category: Pharmaceuticals Source Type: news

NCCN Guidelines to Include Categories of Preference
NCCN categories of preference will provide guidance on which recommendations within the NCCN Guidelines are optimal, while providing a range of recommendations to accommodate a variety of clinical circumstances FORT WASHINGTON, Pa., Sept. 15, 2017 -- (H... Biopharmaceuticals, Devices, Oncology National Comprehensive Cancer Network, NCCN (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 15, 2017 Category: Pharmaceuticals Source Type: news

Janssen Receives CHMP Positive Opinion for Guselkumab Recommending Approval for the Treatment of Moderate to Severe Plaque Psoriasis in the European Union
Pending approval, guselkumab will be the first biologic that selectively blocks interleukin (IL)-23 FOR MEDICAL AND TRADE MEDIA ONLY BEERSE, Belgium, Sept. 15, 2017 -- (Healthcare Sales & Marketing Network) -- Janssen-Cilag International NV annou... Biopharmaceuticals, Dermatology, Regulatory Janssen-Cilag, Janssen, guselkumab, psoriasis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 15, 2017 Category: Pharmaceuticals Source Type: news

SCA Pharmaceuticals Appoints Milton Boyer as Chief Executive Officer
Boyer Brings More Than 25 Years of Experience in the Chemical and Pharmaceutical Industry LITTLE ROCK, Ark., Sept. 15, 2017 -- (Healthcare Sales & Marketing Network) -- SCA Pharmaceuticals (SCA), a leading sterile outsourcing facility specializing in p... Biopharmaceuticals, Personnel SCA Pharmaceuticals (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 15, 2017 Category: Pharmaceuticals Source Type: news

New eShunt System Presented at the American Academy of Neurological Surgery Annual meeting in Santa Barbara, CA
Early in vivo testing results show promise in treating communicating hydrocephalus BOSTON, Sept. 15, 2017 -- (Healthcare Sales & Marketing Network) -- CereVasc, LLC, a company focused on improving the care of patients with communicating hydrocephalus a... Devices, Neurosurgery CereVasc , eShunt System, hydrocephalus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 15, 2017 Category: Pharmaceuticals Source Type: news

Neovii Pharmaceuticals AG Announces New CEO
RAPPERSWIL, Switzerland, September 15, 2017 -- (Healthcare Sales & Marketing Network) -- Alexandre Sudarskis, Chief Executive Officer (CEO) of Neovii Pharmaceuticals will step down as CEO having reached retirement age. Neovii Pharmaceuticals appointed Jue... Biopharmaceuticals, Personnel Neovii Pharmaceuticals (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 15, 2017 Category: Pharmaceuticals Source Type: news

New indication for BRIVIACT(R) (brivaracetam): UCB's newest antiepileptic drug approved by FDA as monotherapy treatment of partial-onset seizures in adults
BRIVIACT® CV provides a new monotherapy treatment option for epilepsy patients 16 years of age and older with partial-onset (focal) seizures, which can be initiated at a therapeutic dose at day one Approval applies a newly established regulatory pat... Biopharmaceuticals, Neurology, FDA UCB, BRIVIACT, brivaracetam, epilepsy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 15, 2017 Category: Pharmaceuticals Source Type: news

Haemonetics Appoints David J. Wilson Plasma Business Unit President
BRAINTREE, Mass., Sept. 14, 2017 -- (Healthcare Sales & Marketing Network) -- Haemonetics Corporation (NYSE: HAE) announced the appointment of David J. Wilson as President, Plasma Business Unit, effective September 18, 2017. Mr. Wilson is a proven busi... Devices, Personnel Haemonetics, plasma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 14, 2017 Category: Pharmaceuticals Source Type: news

Halozyme Licenses New Enhanze Target For $30 Million Upfront Payment, Future Milestones And Royalties
SAN DIEGO, Sept. 14, 2017 -- (Healthcare Sales & Marketing Network) -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) announced today it licensed its ENHANZE® drug-delivery technology to Roche for exclusive development of an undisclosed therapeutic target... Biopharmaceuticals, Drug Delivery, Licensing Halozyme Therapeutics, Roche Group, ENHANZE (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 14, 2017 Category: Pharmaceuticals Source Type: news

Surfacer(R) Inside-Out(R) Access Catheter System to be Showcased at CIRSE 2017 Annual Meeting
Novel system offers a minimally invasive Inside-Out solution to support the achievement of long-term arteriovenous access SAN ANTONIO, Sept. 14, 2017 -- (Healthcare Sales & Marketing Network) -- Bluegrass Vascular Technologies, a private medical techno... Devices, Interventional Bluegrass Vascular Technologies, Surfacer Inside-Out, Access Catheter (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 14, 2017 Category: Pharmaceuticals Source Type: news

Pfizer and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER Trial of XTANDI (enzalutamide) in Patients with Non-Metastatic Castration-Resistant Prostate Cancer
Enzalutamide is the first androgen receptor-inhibitor to demonstrate a statistically significant improvement in metastasis-free survival (MFS) in this patient population in a randomized, controlled clinical trial NEW YORK and TOKYO, Sept. 14, 2017 -- (H... Biopharmaceuticals, Oncology Astellas Pharma, Pfizer, XTANDI, enzalutamide, prostate cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 14, 2017 Category: Pharmaceuticals Source Type: news

Amarin Appoints Mark W. Salyer to New Position of Chief Commercial Officer
BEDMINSTER, N.J. and DUBLIN, Ireland, Sept. 13, 2017 -- (Healthcare Sales & Marketing Network) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Mark W. Salyer has joined Amarin as Chief Commercial Officer. In this newly created position, Mr. Sa... Biopharmaceuticals, Cardiology, Personnel Amarin, Vascepa, icosapent (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 13, 2017 Category: Pharmaceuticals Source Type: news

Mylan Names Dennis Zeleny as Chief Human Relations Officer
HERTFORDSHIRE, England and PITTSBURGH, Sept. 13, 2017 -- (Healthcare Sales & Marketing Network) -- Mylan N.V. (NASDAQ, TASE: MYL) today announced the appointment of Dennis Zeleny as chief human relations officer. Zeleny joins Mylan with 30 years of experi... Biopharmaceuticals, Personnel Mylan (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 13, 2017 Category: Pharmaceuticals Source Type: news

IRRAS Strengthens Executive and Commercial Teams with Appointments of Karl-Matthias Moehlmann and Klemens Fölling
LA JOLLA, Calif., LAICHINGEN, Germany and STOCKHOLM, Sept. 13, 2017 -- (Healthcare Sales & Marketing Network) -- IRRAS, a commercial-stage medical technology company developing breakthrough devices for a broad range of intracranial bleeding applications a... Devices, Neurology, Personnel IRRAS, IRRAflow, stroke, intracranial pressure (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 13, 2017 Category: Pharmaceuticals Source Type: news

Cernostics Announces Leadership Team Expansion
New Commercial Leader Positions Company for Continued Success and Growth BETHLEHEM and PITTSBURGH, Pa., Sept. 12, 2017 -- (Healthcare Sales & Marketing Network) -- Cernostics, a privately-held diagnostics company focused on delivering next-generation c... Diagnostics, Oncology, Personnel Cernostics, TissueCypher, Barrett's Esophagus, esophageal cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 12, 2017 Category: Pharmaceuticals Source Type: news

T.R.U.E. Test(R) Ready-To-Use Patch Test Receives FDA Approval For Pediatric Use
PHOENIX, Sept. 12, 2017 -- (Healthcare Sales & Marketing Network) -- SmartPractice has received FDA approval for T.R.U.E. TEST (truetest.com) ready-to-use patch test panels for pediatric patients as young as 6 years of age. T.R.U.E. TEST is the only FDA-a... Diagnostics, Dermatology, FDA SmartPractice, T.R.U.E. TEST, allergic contact dermatitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 12, 2017 Category: Pharmaceuticals Source Type: news

Aethlon Medical Receives Expedited Access Pathway Designation from FDA to Accelerate U.S. Access to the Hemopurifier(R) as a Treatment for Life-Threatening Viruses
SAN DIEGO, Sept. 12, 2017 -- (Healthcare Sales & Marketing Network) -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that it has received an Expedited Access ... Devices, FDA Aethlon Medical, Hemopurifier (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 12, 2017 Category: Pharmaceuticals Source Type: news

Vasorum Launches Celt ACD(R) Second Generation Vascular Closure Device in the USA
DUBLIN, Ireland, September 12, 2017 -- (Healthcare Sales & Marketing Network) -- Vasorum Ltd, following FDA approval of its PMA supplement, the developer and manufacturer of the novel Celt ACD® vascular closure device has added a 7F sized Celt ACD&reg... Devices, Interventional, Product Launch Vasorum, Celt ACD, vascular closure (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 12, 2017 Category: Pharmaceuticals Source Type: news

Synthetic Biologics Announces Closing of $12 Million Convertible Preferred Stock Financing
ROCKVILLE, Md., Sept. 12, 2017 -- (Healthcare Sales & Marketing Network) -- Synthetic Biologics, Inc. (NYSE American: SYN), a late-stage clinical company developing therapeutics that preserve the microbiome to protect and restore the health of patients, a... Biopharmaceuticals, Venture Capital Synthetic Biologics, ribaxamase (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 12, 2017 Category: Pharmaceuticals Source Type: news